While Cg Oncology Inc has underperformed by -1.11%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CGON fell by -43.94%, with highs and lows ranging from $46.99 to $14.80, whereas the simple moving average fell by -35.48% in the last 200 days.
On April 16, 2025, Scotiabank started tracking Cg Oncology Inc (NASDAQ: CGON) recommending Sector Perform. A report published by TD Cowen on January 07, 2025, Initiated its previous ‘Buy’ rating for CGON. UBS also rated CGON shares as ‘Buy’, setting a target price of $60 on the company’s shares in an initiating report dated October 24, 2024. RBC Capital Mkts Initiated an Outperform rating on September 23, 2024, and assigned a price target of $66. ROTH MKM initiated its ‘Buy’ rating for CGON, as published in its report on August 28, 2024. BofA Securities’s report from June 28, 2024 suggests a price prediction of $65 for CGON shares, giving the stock a ‘Buy’ rating. Morgan Stanley also rated the stock as ‘Overweight’.
Analysis of Cg Oncology Inc (CGON)
Further, the quarter-over-quarter increase in sales is 45500.00%, showing a positive trend in the upcoming months.
One of the most important indicators of Cg Oncology Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -19.18% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 35.30, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and CGON is recording 830.98K average volume. On a monthly basis, the volatility of the stock is set at 9.67%, whereas on a weekly basis, it is put at 5.46%, with a gain of 5.86% over the past seven days. Furthermore, long-term investors anticipate a median target price of $62.38, showing growth from the present price of $20.41, which can serve as yet another indication of whether CGON is worth investing in or should be passed over.
How Do You Analyze Cg Oncology Inc Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 39.60%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 67.15% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CGON shares are owned by institutional investors to the tune of 67.15% at present.
